cardiovascular – media

Close Link between Cytomegalovirus and Cardiovascular Disease

A research team from Brighton and Sussex Medical School (BSMS) have found a close link between a Cytomegalovirus (CMV) and the immune cells that could damage cardiovascular tissue.
- Source: ScienceDaily
- 148
- August 14, 2018
cardiovascular fracture Researches virus
Your Cardiovascular Fitness can Determine your Gut Health

Exercise can slim down our waistlines and boost our healthy heart but a research team from San Francisco State University found that apart from this, exercise can also boost the gut health.
- Source: News Medical
- 173
- July 13, 2018
cardiovascular gut bacteria Researches
Viscofan to Trial Stem Cell Implant for Severe Cardiac Insufficiency

Viscofan BioEngineering, a German medical products manufacturer is to conduct a Phase I clinical trial of its stem cell implant, VB-C01, designed to treat severe cardiac insufficiencies, on receiving a green light from the Spanish Agency for Medicines (AEMPS).
- Source: Verdict Medical Devices
- 268
- July 10, 2018
cardiovascular Researches stem cells
New study links migraines to increased risk of cardiovascular problems

© Provided by AFPRelaxNews Migraine sufferers could be at an increased risk of certain heart problems according to new research.New international research has found that migraine sufferers may also have an increased risk of cardiovascular problems including heart attacks, stroke, blood clots, and an irregular heart rate.
- Source: msn
- 195
- February 8, 2018
cardiovascular migraine Researches
The Effects Of Air Pollution On Human Health

Although it isn’t talked about often, older adults in the United States are turning to drugs and alcohol at an alarming rate. Studies have found that a large population of older Americans are suffering from substance use disorders, and the number is only expected to rise. According to research, the number of Americans aged 50 and older struggling with addiction is expected to nearly double in the coming years, going from 2.8 million to 5.7 million by 2020.
- Source: msn
- 242
- January 24, 2018
air pollution asthma cardiovascular pneumonia
Tudorza reduces exacerbations and demonstrates cardiovascular safety in COPD patients

AstraZeneca today announced positive top-line results of the Phase IV ASCENT trial for Tudorza Pressair (aclidinium bromide 400 μg, twice-daily), a long-acting muscarinic antagonist (LAMA), in patients with moderate to very severe chronic obstructive pulmonary disease (COPD), with a history of cardiovascular disease and/or significant cardiovascular risk factors.
- Source: Astrazeneca
- 186
- December 8, 2017
AstraZeneca cardiovascular Clinical Trials COPD
Salt raises blood pressure, but our gut bacteria can stop it

It's a known fact that too much salt can increase blood pressure. But new research brings gut bacteria into the mix, and some good news along with it: probiotics may help to reverse the harmful effects of excessive salt.
- Source: medicalnewstoday
- 243
- November 17, 2017
blood pressure cardiovascular gut bacteria New Approvals
Jardiance is the first and only oral type 2 diabetes medicine approved to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.

New data presented today showed that Jardiance® reduced the risk of cardiovascular death compared with placebo when added to standard of care in adults with type 2 diabetes and peripheral artery disease.
- Source: finance.yahoo
- 171
- November 17, 2017
cardiovascular diabetes Jardiance® peripheral artery disease
EU OKs low-dose Xarelto to prevent recurrent VTE

A lower dose formulation of Bayer and Janssen’s bloodthinner Xarelto has been approved by European regulators for preventing recurrent venous thromboembolism, expanding treatment options for patients.
- Source: Pharmatimes
- 197
- November 8, 2017
cardiovascular New Approvals venous thromboembolism VTE
Ddu College–Market Report of Coronary Stents

Coronary heart disease is a common illness of cardiovascular disease which is treated mainly through medicines, coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI). Remarkably, PCI is preferable to both clinicians and patients for its short treatment course, small wound and significant therapeutic effects: doctors can use PCI to open coronary arteries that are narrowed or blocked by the buildup of atherosclerotic plaque without thoracotomy. Today, Ddu is going to share the market report of coronary stent with you.
- Source: Ddu
- 384
- October 27, 2017
cardiovascular coronary stent Ddu College

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

Exhibitions & Activitiesmore

Ddu to Attend CPhI in Shanghai Sharing Insights on International Marketing of the Medical Trade

June 19, 2018
IRANPHARMA EXPO 2018

June 14, 2018
Drugdu.com Launches Digital Marketing Strategy Solution for Pharmaceuticals and Medical Devices at CMEF Shanghai 2018

May 8, 2018
Ddu Attended CPhI North America Great Success with the “Internet + Cross-border medical trade” Marketing Model

May 3, 2018
Ddu’s International Medical Exhibition Attendance Delivering High Results.

April 9, 2018

Market Reportsmore

International study puts AliveCor’s smartphone ECG on par with 12-lead system

November 30, 2018
Best healthcare facilities

September 26, 2018
China’s Import and Export Market Report of Diabetes Drugs

May 4, 2018
China’s Import and Export Market Report of Vitamins

April 11, 2018
China’s Import and Export Market Report of Contraceptive Drugs

March 16, 2018

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.